Half-year report · Q2
6823.TEDINET S100UPWS
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥25.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.8bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.6bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.7bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥38.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥37.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥35.6bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.1bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥30.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥29.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥27.6bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥968m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥398m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥566m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥275m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥97.27 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥215.51 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.25 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 78.8% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥139m |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥401m |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥13.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E01842-000Environmental Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥31m |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥6.3bn |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥6.3bn |
| jpcrp040300-q2r_E01842-000Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥763m |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.4bn |
| jpcrp040300-q2r_E01842-000Particle Countersreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥901m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥12.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥12.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 485
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash dividends paid fin cf | Prior1YTDDuration | -269244000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -392941000 | JPY |
| Other net fin cf | Prior1YTDDuration | -5778000 | JPY |
| Other net fin cf | CurrentYTDDuration | -5073000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -275023000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -398015000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | -78507000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 6584000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 356779000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 789576000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 5206561000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 4860213000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 5563341000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 5649790000 | JPY |
| Finished goods | Prior1YearInstant | 2248569000 | JPY |
| Finished goods | CurrentQuarterInstant | 2356407000 | JPY |
| Work in process | Prior1YearInstant | 1473325000 | JPY |
| Work in process | CurrentQuarterInstant | 1812922000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 3485653000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 3989921000 | JPY |
| Salaries sga | Prior1YTDDuration | 1515475000 | JPY |
| Salaries sga | CurrentYTDDuration | 1590044000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 489573000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 502350000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 88724000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 79133000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 248000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -1354000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01842-000ParticleCountersReportableSegmentMember | 3431376000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01842-000MedicalEquipmentReportableSegmentsMember | 6310059000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 2360387000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 12101823000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 12101823000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01842-000ParticleCountersReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01842-000MedicalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E01842-000EnvironmentalEquipmentReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01842-000ParticleCountersReportableSegmentMember | 3431376000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01842-000MedicalEquipmentReportableSegmentsMember | 6310059000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 2360387000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 12101823000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 12101823000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01842-000ParticleCountersReportableSegmentMember | 900773000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01842-000MedicalEquipmentReportableSegmentsMember | 762602000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01842-000EnvironmentalEquipmentReportableSegmentsMember | 31311000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1694687000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |